TechFlame News - According to market data from Gate, as U.S. stocks opened, the Dow Jones Industrial Average fell by 0.33%, the S&P 500 Index dropped by 0.15%, and the Nasdaq Composite Index declined by 0.13%. Novo Nordisk (NVO.N) plummeted by 15.65% after the company stated that the experimental results of its weight-loss drug Cagrisema were not as effective as Eli Lilly's Zepbound. Eli Lilly (LLY.N) opened with a gain of 3.86%.